Product Information
HYDROCORTISONE BUTYR 0.1% OINT is a generic product labeled by Oceanside Pharmaceuticals, priced at $1.8725 per GM under NDC 68682027115. Its NADAC has been published 174 times since Dec 14, 2016.
FDA first approved this application on Oct 29, 1982.
Strength
1 mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682027115
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
3/19/2025
Active Ingredients
HYDROCORTISONE BUTYRATEApproval Type
New Drug (NDA)
FDA Application
NDA018652FDA Approved
10/29/1982
On Market Since
9/1/2009
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORTISONE BUTYR 0.1% OINT has been published 174 times since Dec 14, 2016, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8725 per GM |
|---|---|
| All-time high | $2.9735 (Jan 10, 2018) |
| All-time low | $1.8725 (Jan 22, 2025) |
| Median price | $2.4352 |
| Average price | $2.3731 |
| Largest weekly change | +22.1% (Jun 21, 2017) |
| Weeks tracked | 174 |
| Tracking since | Dec 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-24.5%
5Y
-24.5%
All
-23.1%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocortisone butyrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORTISONE BUTYR 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORTISONE BUTYR 0.1% OINT, manufactured by Oceanside Pharmaceuticals, is $1.8725 per GM (NDC 68682027115), effective Jul 2, 2025.
How has the price of HYDROCORTISONE BUTYR 0.1% OINT changed over time?
Over the history we have for it, the NADAC for HYDROCORTISONE BUTYR 0.1% OINT has declined 23.1%. It has been tracked across 174 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for HYDROCORTISONE BUTYR 0.1% OINT?
Since Dec 14, 2016, the NADAC for HYDROCORTISONE BUTYR 0.1% OINT has ranged from a low of $1.8725 (Jan 22, 2025) to a high of $2.9735 (Jan 10, 2018), with a median of $2.4352 per GM.
Are there cheaper alternatives to HYDROCORTISONE BUTYR 0.1% OINT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCORTISONE BUTYR 0.1% OINT, is $1.7675 per GM — about 6% below HYDROCORTISONE BUTYR 0.1% OINT.
Who manufactures HYDROCORTISONE BUTYR 0.1% OINT?
HYDROCORTISONE BUTYR 0.1% OINT (NDC 68682027115) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.